Signals
When Dementia Takes Speech, Trials Must Catch Up
CervoMed has completed enrolment in a Phase IIa study of neflamapimod in nonfluent/agrammatic primary progressive aphasia. The milestone is small, but the unmet need is not.
Gastric Cancer Gets a New Biomarker Access Signal
The Brain Can Recover. The System Often Does Not Let It.
CIDP Treatment Moves Beyond the IVIg Default
Metastatic Cancer Means Living With Loss Before the End
Dementia Is Not the End of Personhood
mRNA Flu Shots Are No Longer a Pandemic Experiment
MRD Testing Moves From Prognosis Toward Treatment Action
Colon Cancer Immunotherapy Moves Into the Adjuvant Access Test
Optic Neuritis Moves Into the Neuroprotection Race
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.